文献速递心脏核医学

终末期肾病患者肾移植前血管扩张剂负荷心肌灌注显像中心率反应的预后价值

The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.
PubMed 文献 · J Nucl Cardiol · 2017-09-18

回顾性队列分析352例无症状终末期肾病患者,在肾移植前接受血管扩张剂负荷SPECT-MPI,140例心率反应迟钝。平均随访3.2±2.0年发生85例(24%)主要不良心脏事件,心率反应迟钝与MACE风险升高相关(HR 1.72,95%CI 1.12-2.63,P=0.013),且在正常MPI和不同临床风险患者中均有预测价值。

要点

  • 140/352例(40%)移植前心率反应迟钝,定义为瑞加腺苷负荷<28%或腺苷负荷<20%。
  • 心率反应迟钝与MACE风险升高相关(HR 1.72,95%CI 1.12-2.63,P=0.013)。
  • 心率反应迟钝者术后30天MACE发生率17.9% vs 8.5%(P=0.009)。

核心结论

  • 在无症状终末期肾病患者肾移植评估中,移植前心率反应迟钝可预测移植后主要不良心脏事件。
  • 心率反应可能是肾移植候选者风险评估的有价值工具。

研究设计与样本

  • 回顾性队列研究,纳入352例接受血管扩张剂负荷SPECT-MPI并随后行肾移植的无症状终末期肾病患者。
  • 心率反应迟钝定义为瑞加腺苷负荷时心率反应<28%、腺苷负荷时<20%。
  • 主要终点为主要不良心脏事件,定义为心源性死亡或心肌梗死;临床风险采用AHA/ACCF共识声明风险因素总和评估。

主要发现

  • 352例中140例移植前心率反应迟钝。
  • 平均随访3.2±2.0年,共观察到85例(24%)主要不良心脏事件。
  • 心率反应迟钝与MACE风险升高相关(HR 1.72;95%CI 1.12-2.63,P=0.013),校正性别、AHA/ACCF风险因素总和、负荷总评分、基线心率及β受体阻滞剂使用后仍显著。
  • 心率反应对MACE的预测价值见于MPI正常患者,且不受临床风险影响。
  • 心率反应迟钝者术后(30天)MACE风险显著增加(17.9% vs 8.5%;P=0.009)。

关键数值与推荐

  • 心率反应迟钝阈值:瑞加腺苷负荷<28%,腺苷负荷<20%。
  • MACE定义:心源性死亡或心肌梗死。
  • 临床风险评估:AHA/ACCF共识声明风险因素总和。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In asymptomatic end-stage renal disease (ESRD) patients undergoing vasodilator stress myocardial perfusion imaging (MPI) prior to renal transplantation (RT), the impact of pre-transplant heart rate response (HRR) to vasodilator stress on post-RT outcomes is unknown. METHODS: We analyzed a retrospective cohort of asymptomatic patients with ESRD who underwent a vasodilator stress SPECT-MPI and subsequently received RT. Blunted HRR was defined as HRR <28% for regadenoson stress and <20% for adenosine stress. The primary endpoint was major adverse cardiac events (MACE), defined as cardiac death or myocardial infarction. Clinical risk was assessed using the sum of risk factors set forth by the AHA/ACCF consensus statement on the assessment of RT candidates. RESULTS: Among 352 subjects, 140 had an abnormal pre-transplant HRR. During a mean follow-up of 3.2 ± 2.0 years, 85 (24%) MACEs were observed. Blunted HRR was associated with increased MACE risk (hazard ratio 1.72; 95% confidence interval 1.12-2.63, P = 0.013), and remained significant after adjustment for gender, sum of AHA/ACCF risk factors, summed stress score, baseline heart rate, and β-blocker use. HRR was predictive of MACE in patients with normal MPI and irrespective of clinical risk. Blunted HRR was associated with a significant increase in post-operative (30-day) MACE risk (17.9% vs 8.5%; P = 0.009). CONCLUSION: In asymptomatic ESRD patients being evaluated for RT, a blunted pre-transplant HRR was predictive of post-RT MACE. HRR may be a valuable tool in the risk assessment of RT candidates.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. AlJaroudi W, Anokwute C, Fughhi I, et al. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2017. PMID: 28924814. doi:10.1007/s12350-017-1061-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。